{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:14:01Z","timestamp":1760044441413,"version":"3.35.0"},"reference-count":49,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,8,19]],"date-time":"2008-08-19T00:00:00Z","timestamp":1219104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Although current treatments for opioid detoxification are not always effective, medical detoxification remains a required step before long\u2010term interventions. The use of opioid antagonist medications to improve detoxification has produced inconsistent results. Very low dose naltrexone (VLNTX) was recently found to reduce opioid tolerance and dependence in animal and clinical studies. We decided to evaluate safety and efficacy of VLNTX adjunct to methadone in reducing withdrawal during detoxification. In a multi\u2010center, double\u2010blind, randomized study at community treatment programs, where most detoxifications are performed, 174 opioid\u2010dependent subjects received NTX 0.125\u2003mg, 0.250\u2003mg or placebo daily for 6 days, together with methadone in tapering doses. VLNTX\u2010treated individuals reported attenuated withdrawal symptoms [<jats:italic>F<\/jats:italic>\u2003=\u20037.24 (2,170);<jats:italic>P<\/jats:italic>\u2003=\u20030.001] and reduced craving [<jats:italic>F<\/jats:italic>\u2003=\u20033.73 (2,107);<jats:italic>P<\/jats:italic>\u2003=\u20030.03]. Treatment effects were more pronounced at discharge and were not accompanied by a significantly higher retention rate. There were no group differences in use of adjuvant medications and no treatment\u2010related adverse events. Further studies should explore the use of VLNTX, combined with full and partial opioid agonist medications, in detoxification and long\u2010term treatment of opioid dependence.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2008.00119.x","type":"journal-article","created":{"date-parts":[[2008,8,19]],"date-time":"2008-08-19T15:57:15Z","timestamp":1219161435000},"page":"204-213","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["CLINICAL STUDY: Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial"],"prefix":"10.1111","volume":"14","author":[{"given":"Paolo","family":"Mannelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin A.","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathi","family":"Peindl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li\u2010Tzy","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Gottheil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,5]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.002"},{"key":"e_1_2_6_3_1","first-page":"CD003409","article-title":"Methadone at tapered doses for the management of opioid withdrawal","volume":"20","author":"Amato L","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_4_1","unstructured":"American Psychiatric Association(2000) Diagnostic criteria from DSM\u2010IV\u2010TR \/ American Psychiatric Association. Washington D.C."},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00027-7"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n01_12"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00063-0"},{"key":"e_1_2_6_8_1","first-page":"115","volume-title":"Recent developments in Pain Research","author":"Burns LH","year":"2005"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000162804.38829.97"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290110077013"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-100103117"},{"volume-title":"Statistical Power Analyses for the Social Science","year":"1988","author":"Cohen J","key":"e_1_2_6_12_1"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.8.903"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)03010-9"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00959.x"},{"key":"e_1_2_6_16_1","first-page":"474","article-title":"Frequency and causes of premature termination (drop\u2010out) during in\u2010patient opiate detoxification","volume":"69","author":"Gossling HW","year":"2001","journal-title":"Fortschr Neurol Psychiatr"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6584.1377"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yco.0000218596.54054.a1"},{"key":"e_1_2_6_19_1","first-page":"CD002025.","article-title":"Buprenorphine for the management of opioid withdrawal","volume":"18","author":"Gowing L","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_20_1","first-page":"CD002022.","article-title":"Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal","volume":"19","author":"Gowing L","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00186-X"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952998709001515"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2004.12.004"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0708"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01402.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0022-3565(25)11239-1","article-title":"Clinical characteristics of naloxone\u2010precipitated withdrawal in human opioid\u2010dependent subjects","volume":"260","author":"Kanof PD","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952998709001497"},{"key":"e_1_2_6_28_1","first-page":"5","article-title":"Buprenorphine in primary HIV care clinics: a big pill to swallow","volume":"16","author":"Lucas GM","year":"2004","journal-title":"Hopkins HIV Rep"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0740-5472(92)90062-S"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.2307\/3350433"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v22n02_05"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.05.013"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v25n02_01"},{"key":"e_1_2_6_34_1","first-page":"CD002209.","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2","author":"Mattick RP","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.22.1936"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(94)90166-X"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.3.229"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.07.008"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952999709040946"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.2.588"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.02.003"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318032ec2a"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91516-0"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(97)00197-2"},{"key":"e_1_2_6_45_1","first-page":"CD001867.","article-title":"Opioid antagonists for alcohol dependence","volume":"25","author":"Srisurapanont M","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"volume-title":"Treatment Episode and Data Set Highlights\u20102005","year":"2007","author":"Substance Abuse and Mental Health Services Administration","key":"e_1_2_6_46_1"},{"volume-title":"DASIS Report: Heroin Trends\u2010Changes in How it is Used 1995\u20132005","year":"2007","author":"Substance Abuse and Mental Health Services Administration","key":"e_1_2_6_47_1"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.20738"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2005.06.003"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.05.005"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2008.00119.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2008.00119.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:43:23Z","timestamp":1738338203000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2008.00119.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,5]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["10.1111\/j.1369-1600.2008.00119.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2008.00119.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"type":"print","value":"1355-6215"},{"type":"electronic","value":"1369-1600"}],"subject":[],"published":{"date-parts":[[2009,3,5]]},"assertion":[{"value":"2009-03-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}